all the information, none of the junk | biotech • healthcare • life sciences

Ligand Nabs $2M From Merck

Xconomy San Diego — 

San Diego-based Ligand Pharmaceuticals (NASDAQ: LGND) said today it has received $2 million in milestone payments as part of research collaboration with Merck that is due to expire next month. The partnership started with Organon, which was later acquired by Schering-Plough, which was then acquired by Merck.